United States Biotechnology & Medical Research

FibroGen Inc (FGEN)

Track

Track

FibroGen Inc. experienced recent insider activity involving CEO Thane Wettig, who executed multiple share purchases in November 2025. These acquisitions represent the latest recorded transactions for the firm. Prior to this period, other executives also engaged in buying activity throughout the year, reflecting a consistent pattern of accumulation by leadership personnel.
Ticker: FGEN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for FibroGen Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
419.07
Quantity 90,964 -44.1%
Value US$2,490,824
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
338.48
Quantity 75,147 -37.7%
Value US$4,830,116
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
349.78
Quantity 9,356 -8.1%
Value US$1,829,287
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
0.35
Quantity 145,000 +36.4%
Value US$50,663
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
0.34
Quantity 50,000 +15.4%
Value US$17,040
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
0.35
Quantity 250,000 +339.1%
Value US$88,000
0.5
Adib Deyaa Chief Medical Officer Officer
Transaction date
Purchase
Price
1.17
Quantity 22,123 +36.9%
Value US$25,884
3.6
Wettig Thane CEO Officer
Transaction date
Purchase
Price
1.91
Quantity 50,000 +11.9%
Value US$95,470
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
1.06
Quantity 2,000
Value US$2,120
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
1.91
Quantity 2,000
Value US$3,820
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
2.69
Quantity 2,000 -5.7%
Value US$5,380
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
2.73
Quantity 2,000
Value US$5,460
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.80
Quantity 1,880 -0.5%
Value US$5,264
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
16.53
Quantity 791 -0.7%
Value US$13,075
3.6
Wettig Thane Officer Officer
Transaction date
Proposed sale
Price
16.53
Quantity 791
Value US$13,075
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
17.46
Quantity 1,000 -0.4%
Value US$17,460
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
16.66
Quantity 5,250 -2.2%
Value US$87,465
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
17.60
Quantity 6,250 -2.5%
Value US$110,000
3.9
Christine Chung Officer Officer
Transaction date
Proposed sale
Price
17.56
Quantity 62,500
Value US$1,097,500
AOIFE BRENNAN Director Non-Executive Director
Transaction date
Proposed sale
Price
17.19
Quantity 4,733
Value US$81,363
SUZANNE BLAUG Director Non-Executive Director
Transaction date
Proposed sale
Price
17.20
Quantity 8,520
Value US$146,553
JEFFREY L EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
17.19
Quantity 7,889
Value US$135,607
BENJAMIN CRAVATT Director Non-Executive Director
Transaction date
Proposed sale
Price
17.17
Quantity 3,944
Value US$67,723
Brennan Aoife Non-Executive Director
Transaction date
Planned sale
Price
17.52
Quantity 2,739 -8.9%
Value US$47,987
Brennan Aoife Non-Executive Director
Transaction date
Planned sale
Price
16.74
Quantity 1,994 -6.1%
Value US$33,380
EDWARDS JEFFREY L Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 4,624 -12.0%
Value US$80,966
EDWARDS JEFFREY L Non-Executive Director
Transaction date
Planned sale
Price
16.74
Quantity 3,265 -7.8%
Value US$54,656
Blaug Suzanne Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 5,169 -14.9%
Value US$90,509
Blaug Suzanne Non-Executive Director
Transaction date
Planned sale
Price
16.73
Quantity 3,351 -8.8%
Value US$56,062
Cravatt Benjamin Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 2,178 -7.0%
Value US$38,137
Cravatt Benjamin Non-Executive Director
Transaction date
Planned sale
Price
16.75
Quantity 1,766 -5.4%
Value US$29,580
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
17.69
Quantity 4,994 -12.5%
Value US$88,344
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
16.87
Quantity 2,006 -4.8%
Value US$33,841
Ho Maykin Non-Executive Director
Transaction date
Planned sale
Price
17.68
Quantity 6,225 -16.5%
Value US$110,058
Ho Maykin Non-Executive Director
Transaction date
Planned sale
Price
16.79
Quantity 2,295 -5.7%
Value US$38,533
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
17.78
Quantity 7,000
Value US$124,460
May-Kin Ho Director Non-Executive Director
Transaction date
Proposed sale
Price
17.78
Quantity 8,520
Value US$151,486
3.9
Graham Juan Officer Officer
Transaction date
Proposed sale
Price
16.95
Quantity 1,050
Value US$17,797
4.0
Eisner Mark EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
17.04
Quantity 2,042 -1.2%
Value US$34,792
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
17.04
Quantity 1,286 -1.1%
Value US$21,910
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.04
Quantity 472 -0.4%
Value US$8,041
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
17.04
Quantity 6,106 -1.6%
Value US$104,033
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
17.04
Quantity 2,791 -0.7%
Value US$47,550
3.1
Schoeneck James A Non-Executive Director
Transaction date
Planned sale
Price
18.03
Quantity 7,100 -8.8%
Value US$127,987
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
17.04
Quantity 735 -1.0%
Value US$12,523
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
16.95
Quantity 1,050 -1.4%
Value US$17,797
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 1,532 -0.6%
Value US$26,102
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 739 -0.3%
Value US$12,590
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 1,362 -0.5%
Value US$23,202
3.1
Schoeneck James A Director Non-Executive Director
Transaction date
Proposed sale
Price
18.03
Quantity 7,100
Value US$127,987
3.9
Graham Juan Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 1,406
Value US$23,956
3.6
Wettig Thane Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 1,758
Value US$29,951
4.0
Eisner Mark Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 2,042
Value US$34,792
3.9
Chung Christine Officer Officer
Transaction date
Proposed sale
Price
17.02
Quantity 3,633
Value US$61,839
4.0
Eisner Mark EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
18.83
Quantity 1,090 -0.7%
Value US$20,525
4.0
Eisner Mark Officer Officer
Transaction date
Proposed sale
Price
18.83
Quantity 1,090
Value US$20,525
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
19.52
Quantity 1,869 -0.5%
Value US$36,483
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
18.78
Quantity 9,182 -5.2%
Value US$172,473
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
18.78
Quantity 6,590 -2.5%
Value US$123,785
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
18.71
Quantity 905 -0.8%
Value US$16,933
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 2,344 -3.1%
Value US$47,342
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 1,456 -1.9%
Value US$29,407
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 1,112 -1.4%
Value US$22,459
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
20.20
Quantity 19,486 -4.8%
Value US$393,565
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
20.20
Quantity 12,103 -2.9%
Value US$244,448
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
20.20
Quantity 6,255 -3.4%
Value US$126,334
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
20.20
Quantity 3,885 -2.1%
Value US$78,467
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 4,731 -4.1%
Value US$95,553
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 2,938 -2.5%
Value US$59,340
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
20.20
Quantity 2,914 -1.1%
Value US$58,855
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
20.20
Quantity 4,692 -1.8%
Value US$94,766
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
21.16
Quantity 2,749 -3.8%
Value US$58,158
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
21.16
Quantity 24,672 -6.5%
Value US$521,958
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-17 2025-11-17 B Purchase
3.6
Wettig Thane

CEO

Executive Director
90,964 -44.1%
419.07
US$2,490,824 		90,964 -44.1% 419.07 US$2,490,824
2025-11-17 2025-11-13 B Purchase
3.6
Wettig Thane

CEO

Executive Director
75,147 -37.7%
338.48
US$4,830,116 		75,147 -37.7% 338.48 US$4,830,116
2025-07-02 2025-06-30 B Purchase
3.1
Schoeneck James A
Non-Executive Director
9,356 -8.1%
349.78
US$1,829,287 		9,356 -8.1% 349.78 US$1,829,287
2025-03-25 2025-03-24 B Purchase
3.6
Wettig Thane

CEO

Executive Director
145,000 +36.4%
0.35
US$50,663 		145,000 +36.4% 0.35 US$50,663
2025-03-24 2025-03-21 B Purchase
3.1
Schoeneck James A
Non-Executive Director
50,000 +15.4%
0.34
US$17,040 		50,000 +15.4% 0.34 US$17,040
2025-03-24 2025-03-20 B Purchase
3.1
Schoeneck James A
Non-Executive Director
250,000 +339.1%
0.35
US$88,000 		250,000 +339.1% 0.35 US$88,000
2024-06-13 2024-06-12 B Purchase
0.5
Adib Deyaa

Chief Medical Officer

Officer
22,123 +36.9%
1.17
US$25,884 		22,123 +36.9% 1.17 US$25,884
2024-03-11 2024-03-07 B Purchase
3.6
Wettig Thane

CEO

Officer
50,000 +11.9%
1.91
US$95,470 		50,000 +11.9% 1.91 US$95,470
2023-09-06 2023-09-01 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -6.5%
1.03
US$2,060 		2,000 -6.5% 1.03 US$2,060
2023-09-01 2023-09-01 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
1.06
US$2,120 		2,000 1.06 US$2,120
2023-08-08 2023-08-04 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -6.1%
1.91
US$3,820 		2,000 -6.1% 1.91 US$3,820
2023-08-04 2023-08-04 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
1.91
US$3,820 		2,000 1.91 US$3,820
2023-07-13 2023-07-11 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -5.7%
2.69
US$5,380 		2,000 -5.7% 2.69 US$5,380
2023-07-11 2023-07-11 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
2.73
US$5,460 		2,000 2.73 US$5,460
2023-07-10 2023-07-07 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
1,880 -0.5%
2.80
US$5,264 		1,880 -0.5% 2.80 US$5,264
2023-06-26 2023-06-23 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
791 -0.7%
16.53
US$13,075 		791 -0.7% 16.53 US$13,075
2023-06-23 2023-06-23 PrS Proposed sale
3.6
Wettig Thane

Officer

Officer
791
16.53
US$13,075 		791 16.53 US$13,075
2023-06-15 2023-06-14 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
1,000 -0.4%
17.46
US$17,460 		1,000 -0.4% 17.46 US$17,460
2023-06-15 2023-06-14 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
5,250 -2.2%
16.66
US$87,465 		5,250 -2.2% 16.66 US$87,465
2023-06-15 2023-06-13 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
6,250 -2.5%
17.60
US$110,000 		6,250 -2.5% 17.60 US$110,000
2023-06-13 2023-06-13 PrS Proposed sale
3.9
Christine Chung

Officer

Officer
62,500
17.56
US$1,097,500 		62,500 17.56 US$1,097,500
2023-06-09 2023-06-09 PrS Proposed sale
AOIFE BRENNAN

Director

Non-Executive Director
4,733
17.19
US$81,363 		4,733 17.19 US$81,363
2023-06-09 2023-06-09 PrS Proposed sale
SUZANNE BLAUG

Director

Non-Executive Director
8,520
17.20
US$146,553 		8,520 17.20 US$146,553
2023-06-09 2023-06-09 PrS Proposed sale
JEFFREY L EDWARDS

Director

Non-Executive Director
7,889
17.19
US$135,607 		7,889 17.19 US$135,607
2023-06-09 2023-06-09 PrS Proposed sale
BENJAMIN CRAVATT

Director

Non-Executive Director
3,944
17.17
US$67,723 		3,944 17.17 US$67,723
2023-06-09 2023-06-09 PlS Planned sale
Brennan Aoife
Non-Executive Director
2,739 -8.9%
17.52
US$47,987 		2,739 -8.9% 17.52 US$47,987
2023-06-09 2023-06-09 PlS Planned sale
Brennan Aoife
Non-Executive Director
1,994 -6.1%
16.74
US$33,380 		1,994 -6.1% 16.74 US$33,380
2023-06-09 2023-06-09 PlS Planned sale
EDWARDS JEFFREY L
Non-Executive Director
4,624 -12.0%
17.51
US$80,966 		4,624 -12.0% 17.51 US$80,966
2023-06-09 2023-06-09 PlS Planned sale
EDWARDS JEFFREY L
Non-Executive Director
3,265 -7.8%
16.74
US$54,656 		3,265 -7.8% 16.74 US$54,656
2023-06-09 2023-06-09 PlS Planned sale
Blaug Suzanne
Non-Executive Director
5,169 -14.9%
17.51
US$90,509 		5,169 -14.9% 17.51 US$90,509
2023-06-09 2023-06-09 PlS Planned sale
Blaug Suzanne
Non-Executive Director
3,351 -8.8%
16.73
US$56,062 		3,351 -8.8% 16.73 US$56,062
2023-06-09 2023-06-09 PlS Planned sale
Cravatt Benjamin
Non-Executive Director
2,178 -7.0%
17.51
US$38,137 		2,178 -7.0% 17.51 US$38,137
2023-06-09 2023-06-09 PlS Planned sale
Cravatt Benjamin
Non-Executive Director
1,766 -5.4%
16.75
US$29,580 		1,766 -5.4% 16.75 US$29,580
2023-06-09 2023-06-08 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
4,994 -12.5%
17.69
US$88,344 		4,994 -12.5% 17.69 US$88,344
2023-06-09 2023-06-08 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,006 -4.8%
16.87
US$33,841 		2,006 -4.8% 16.87 US$33,841
2023-06-09 2023-06-08 PlS Planned sale
Ho Maykin
Non-Executive Director
6,225 -16.5%
17.68
US$110,058 		6,225 -16.5% 17.68 US$110,058
2023-06-09 2023-06-08 PlS Planned sale
Ho Maykin
Non-Executive Director
2,295 -5.7%
16.79
US$38,533 		2,295 -5.7% 16.79 US$38,533
2023-06-08 2023-06-08 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
7,000
17.78
US$124,460 		7,000 17.78 US$124,460
2023-06-08 2023-06-08 PrS Proposed sale
May-Kin Ho

Director

Non-Executive Director
8,520
17.78
US$151,486 		8,520 17.78 US$151,486
2023-06-08 2023-06-08 PrS Proposed sale
3.9
Graham Juan

Officer

Officer
1,050
16.95
US$17,797 		1,050 16.95 US$17,797
2023-06-09 2023-06-07 S Sale
4.0
Eisner Mark

EVP, Chief Medical Officer

Officer
2,042 -1.2%
17.04
US$34,792 		2,042 -1.2% 17.04 US$34,792
2023-06-09 2023-06-07 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
1,286 -1.1%
17.04
US$21,910 		1,286 -1.1% 17.04 US$21,910
2023-06-09 2023-06-07 PlS Planned sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
472 -0.4%
17.04
US$8,041 		472 -0.4% 17.04 US$8,041
2023-06-09 2023-06-07 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
6,106 -1.6%
17.04
US$104,033 		6,106 -1.6% 17.04 US$104,033
2023-06-09 2023-06-07 PlS Planned sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
2,791 -0.7%
17.04
US$47,550 		2,791 -0.7% 17.04 US$47,550
2023-06-09 2023-06-07 PlS Planned sale
3.1
Schoeneck James A
Non-Executive Director
7,100 -8.8%
18.03
US$127,987 		7,100 -8.8% 18.03 US$127,987
2023-06-09 2023-06-07 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
735 -1.0%
17.04
US$12,523 		735 -1.0% 17.04 US$12,523
2023-06-09 2023-06-07 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,050 -1.4%
16.95
US$17,797 		1,050 -1.4% 16.95 US$17,797
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
1,532 -0.6%
17.04
US$26,102 		1,532 -0.6% 17.04 US$26,102
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
739 -0.3%
17.04
US$12,590 		739 -0.3% 17.04 US$12,590
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
1,362 -0.5%
17.04
US$23,202 		1,362 -0.5% 17.04 US$23,202
2023-06-07 2023-06-07 PrS Proposed sale
3.1
Schoeneck James A

Director

Non-Executive Director
7,100
18.03
US$127,987 		7,100 18.03 US$127,987
2023-06-07 2023-06-07 PrS Proposed sale
3.9
Graham Juan

Officer

Officer
1,406
17.04
US$23,956 		1,406 17.04 US$23,956
2023-06-07 2023-06-07 PrS Proposed sale
3.6
Wettig Thane

Officer

Officer
1,758
17.04
US$29,951 		1,758 17.04 US$29,951
2023-06-07 2023-06-07 PrS Proposed sale
4.0
Eisner Mark

Officer

Officer
2,042
17.04
US$34,792 		2,042 17.04 US$34,792
2023-06-07 2023-06-07 PrS Proposed sale
3.9
Chung Christine

Officer

Officer
3,633
17.02
US$61,839 		3,633 17.02 US$61,839
2023-06-05 2023-06-02 S Sale
4.0
Eisner Mark

EVP, Chief Medical Officer

Officer
1,090 -0.7%
18.83
US$20,525 		1,090 -0.7% 18.83 US$20,525
2023-06-02 2023-06-02 PrS Proposed sale
4.0
Eisner Mark

Officer

Officer
1,090
18.83
US$20,525 		1,090 18.83 US$20,525
2023-04-11 2023-04-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
1,869 -0.5%
19.52
US$36,483 		1,869 -0.5% 19.52 US$36,483
2023-04-06 2023-04-04 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
9,182 -5.2%
18.78
US$172,473 		9,182 -5.2% 18.78 US$172,473
2023-04-06 2023-04-04 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
6,590 -2.5%
18.78
US$123,785 		6,590 -2.5% 18.78 US$123,785
2023-03-24 2023-03-23 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
905 -0.8%
18.71
US$16,933 		905 -0.8% 18.71 US$16,933
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
2,344 -3.1%
20.20
US$47,342 		2,344 -3.1% 20.20 US$47,342
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,456 -1.9%
20.20
US$29,407 		1,456 -1.9% 20.20 US$29,407
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,112 -1.4%
20.20
US$22,459 		1,112 -1.4% 20.20 US$22,459
2023-03-10 2023-03-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
19,486 -4.8%
20.20
US$393,565 		19,486 -4.8% 20.20 US$393,565
2023-03-10 2023-03-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
12,103 -2.9%
20.20
US$244,448 		12,103 -2.9% 20.20 US$244,448
2023-03-10 2023-03-10 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
6,255 -3.4%
20.20
US$126,334 		6,255 -3.4% 20.20 US$126,334
2023-03-10 2023-03-10 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
3,885 -2.1%
20.20
US$78,467 		3,885 -2.1% 20.20 US$78,467
2023-03-10 2023-03-10 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
4,731 -4.1%
20.20
US$95,553 		4,731 -4.1% 20.20 US$95,553
2023-03-10 2023-03-10 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
2,938 -2.5%
20.20
US$59,340 		2,938 -2.5% 20.20 US$59,340
2023-03-10 2023-03-10 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
2,914 -1.1%
20.20
US$58,855 		2,914 -1.1% 20.20 US$58,855
2023-03-10 2023-03-10 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
4,692 -1.8%
20.20
US$94,766 		4,692 -1.8% 20.20 US$94,766
2023-03-10 2023-03-08 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
2,749 -3.8%
21.16
US$58,158 		2,749 -3.8% 21.16 US$58,158
2023-03-10 2023-03-08 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
24,672 -6.5%
21.16
US$521,958 		24,672 -6.5% 21.16 US$521,958
Explore more

More insider trading research around FibroGen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America